The central nervous system manifestations of systemic lupus erythematosus (SLE) remain poorly understood. Given the well-defined role of autoantibodies in other lupus manifestations, extensive work has gone into the identification of neuropathic autoantibodies. However, attempts to translate these findings to patients with SLE have yielded mixed results. We used the MRL/MpJ-Fas lpr/lpr mouse, a well-established, spontaneous model of SLE, to establish the immune effectors responsible for brain disease. Transcriptomic analysis of the MRL/MpJ-Fas lpr/lpr choroid plexus revealed an expression signature driving tertiary lymphoid structure formation, including chemokines related to stromal reorganization and lymphocyte compartmentalization. Additionally, transcriptional profiles indicated various stages of lymphocyte activation and germinal center formation. The extensive choroid plexus infiltrate present in MRL/MpJ-Fas lpr/lpr mice with overt neurobehavioral deficits included locally proliferating B and T cells, intercellular interactions between lymphocytes and antigen-presenting cells, as well as evidence for in situ somatic hypermutation and class switch recombination. Furthermore, the choroid plexus was a site for trafficking lymphocytes into the brain. Finally, histological evaluation in human lupus patients with neuropsychiatric manifestations revealed increased leukocyte migration through the choroid plexus. These studies identify a potential new pathway underlying neuropsychiatric lupus and support tertiary lymphoid structure formation in the choroid plexus as a novel mechanism of brain-immune interfacing.
Introduction
Systemic lupus erythematosus (SLE) is a complex, multifactorial autoimmune disease with diverse end-organ targets. The pathogenic mechanisms underlying many manifestations of SLE have been extensively characterized, with growing consensus regarding renal, vascular, and cutaneous presentations (1) . Generally, these pathologies are attributable to autoreactive antibodies specific for tissue antigenic determinants and immune complex formation, coupled with downstream cell-and cytokine-mediated inflammation. The central nervous system (CNS) manifestations of SLE, though, have proved more challenging to understand. Signs and symptoms of neuropsychiatric SLE (NPSLE) are quite variable between patients, including focal manifestations closely related to lupus-associated hypercoagulability, as well as diffuse syndromes that include depression, anxiety, memory deficits, and general cognitive decline. The etiology of the diffuse cognitive and emotional manifestations of NPSLE is, however, poorly understood.
Several studies have found that extraneurally derived, neuropathic autoantibodies may be effectors of NPSLE, including anti-ribosomal-P (2) and anti-NMDA receptor antibodies (3) . However, we recently showed that late reversal of systemic autoimmunity, including decreased autoantibody titers, does not fully prevent NPSLE in the classic MRL/MpJ-Fas lpr/lpr (MRL/lpr) mouse model of SLE (4) (5) (6) . Additionally, it is remarkable that certain features of NPSLE may precede diagnosis of SLE in both mouse models and human disease (7) (8) (9) and that systemic immunosuppression and symptomatic therapeutic modalities are inconsistently effective, suggesting that NPSLE may develop distinctly from SLE involvement in other organs as well as other neuropsychiatric diseases.
The central nervous system manifestations of systemic lupus erythematosus (SLE) remain poorly understood. Given the well-defined role of autoantibodies in other lupus manifestations, extensive work has gone into the identification of neuropathic autoantibodies. However, attempts to translate these findings to patients with SLE have yielded mixed results. We used the MRL/ MpJ-Fas lpr/lpr mouse, a well-established, spontaneous model of SLE, to establish the immune effectors responsible for brain disease. Transcriptomic analysis of the MRL/MpJ-Fas lpr/lpr choroid plexus revealed an expression signature driving tertiary lymphoid structure formation, including chemokines related to stromal reorganization and lymphocyte compartmentalization. Additionally, transcriptional profiles indicated various stages of lymphocyte activation and germinal center formation. The extensive choroid plexus infiltrate present in MRL/MpJ-Fas lpr/lpr mice with overt neurobehavioral deficits included locally proliferating B and T cells, intercellular interactions between lymphocytes and antigen-presenting cells, as well as evidence for in situ somatic hypermutation and class switch recombination. Furthermore, the choroid plexus was a site for trafficking lymphocytes into the brain. Finally, histological evaluation in human lupus patients with neuropsychiatric manifestations revealed increased leukocyte migration through the choroid plexus. These studies identify a potential new pathway underlying neuropsychiatric lupus and support tertiary lymphoid structure formation in the choroid plexus as a novel mechanism of brainimmune interfacing.
Prevailing notions about the interface between the CNS and the immune system have undergone significant change in recent years. A novel mechanism of interstitial fluid clearance from the neuropil has been defined as the "glymphatic" system (10) , which conducts cerebrospinal fluid flow from the subarachnoid space through the perivascular space of medium-sized vessels, bounded by the astrocytic foot processes of the neurovascular unit. Additionally, a recently rediscovered lymphatic system appears to reside within the dural sinuses (11), allowing for direct immunosurveillance and transmission of brain antigens to the deep cervical lymph nodes. Finally, the choroid plexus (CP), a cuboidal epithelial bilayer surrounding a highly vascularized capillary plexus, has recently been identified as an important interface for CNS immunosurveillance, within both homeostatic and inflammatory contexts. Specifically, it has been shown that the CP hosts a CD4
+ T cell population demonstrating T cell receptor enrichment for neural antigens (12) and that during CNS infection (13) and experimental autoimmune encephalomyelitis (14) , the CP serves as an important gateway for inflammatory responses.
The CP has historically been implicated in NPSLE as well, with evidence of IgG deposition and MRI findings suggestive of localized inflammation, though a causal relationship has not been demonstrated (15) (16) (17) (18) . Similarly, in the MRL/lpr murine model of SLE, there is an extensive and progressive cellular infiltration within the CP that correlates with development of behavioral abnormalities (19) . This infiltration has been previously characterized as mixed, with accumulations of predominately B and T lymphocytes, as well as plasma cells (20, 21) . However, little has been done to carefully phenotype these brain-infiltrating lymphocytes in mice with lupus or in human disease or evaluate their role in disease pathogenesis.
Chronic inflammation, as it occurs in SLE, is conducive to the formation of tertiary lymphoid structures (TLSs) (22, 23) . The diverse cytokine and chemokine repertoire found in chronically inflamed tissues, including upregulated lymphotoxin-α/-β (LT-α/-β) (24) and CXCL13 (25, 26) , creates the conditions needed to generate these structures. Stromal LT receptor signaling is important in generating the microarchitecture required for efficient antigen presentation and follicle organization, which typically includes collagen-rich reticular cords that serve as conduits for cellular traffic. Similarly, CXCL13 is important in defining local B cell domains (27) . Additionally, other cytokines and chemokines may contribute to the process of lymphoid follicle generation. Finally, certain cellular subsets are critical for the formation of ectopic lymphoid tissues with functional germinal centers (GCs), including B cells with GC activity, CD4 + T cell help provided by T follicular helper (Tfh) or Tfh-like cells, as well as antigen-presenting cells, be they tissue resident or peripherally derived (28) .
Given the early development of neuropsychiatric relative to systemic manifestations of lupus, the relative resistance of NPSLE to systemic immunosuppression, and the existence of specific neuropathic antibodies, with our potentially novel findings described below, we conclude that the prominent mixed cellular infiltrate in the CP of mice with lupus represents a TLS, likely generated in response to signals that are both local CP epithelial derived as well as CNS derived. These TLSs potentially produce clonotypic responses to CNS antigens as a mechanism of bypassing the immune privilege of the CNS. Of broader significance, we report for the first time to our knowledge the presence of organized lymphoid structures within the CP, providing another potential mechanism through which the immune system can interact with the CNS. Finally, transcriptome analysis revealed a unique expression signature in the CP of mice with lupus, consisting of the chemoattractant, organizational, and cell-phenotypical features of an organized TLS. These observations, coupled with evidence of leukocyte migration through the CP of patients with lupus, may provide for novel avenues of therapeutic intervention.
Results
The mixed cellular infiltrate in the CP is structurally organized. We performed immunofluorescence evaluation of the CP infiltrate in 16-to 17-week-old female MRL/lpr mice as an initial screen of the leukocyte types present within the mixed infiltrate, as well as their organizational properties. In all cases, MRL/MpJ-Fas +/+ (MRL/+) control mice were included, though these were uniformly negative for all leukocyte subtypes with the exception of an occasional CD3 + cell (Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/jci.insight.124203DS1). It is noteworthy that, with little exception, leukocyte infiltration into the CP of MRL/lpr mice occurs with complete penetrance, both in our extensive experience as well as in that of others (20, 29, 30) . As a first indication of an organizational structure, we observed defined clusters of B220 + and CD4 + cells, as well as areas of colocalization ( Figure 1A ). The majority of CD3 + cells were CD4 + ( Figure 1B) , with less representation of CD8 + ( Figure 1C ). It is noteworthy that only rarely could we identify double-negative T cells, despite their dominance in the lymphoproliferative phenotype characteristic of the MRL/lpr strain (31) (32) (33) . To identify extracellular features of the cellular infiltrate for clues as to what determines its organizational framework, we stained for reticulin, finding extensive organization of leukocytes around cord-like structures, which was confirmed by transmission electron microscopy (TEM) (Figure 2 ). Elevated expression of lymphoid tissue inducing and regulating molecules in the MRL/lpr CP. We performed transcriptomic analysis on CP samples isolated from 12-to 16-week-old MRL/lpr and MRL/+ mice in an effort to correlate our histological findings with a transcriptional signature consistent with TLS formation. Age-matched murine lymphoid tissue (lymph node) from an unmanipulated non-autoimmune strain was analyzed as a positive control for lymphoid tissue-specific genes. When unsupervised hierarchical clustering was performed selecting the 200 most variable genes, several clusters of genes overlapped between MRL/+ and MRL/lpr CP but were absent from lymph nodes, indicating a set of CP-specific genes ( Figure 3A) . Interestingly, 2 sets of genes were expressed in both MRL/lpr CP and lymph nodes but were absent from MRL/+ CP ( Figure 3A , outlined in red; the full list of genes is provided in Supplemental Table 2 ). Differential expression analysis was performed comparing MRL/lpr relative to MRL/+ CP, yielding a group of 1588 significantly upregulated genes and 83 downregulated genes ( Figure 3B ). Focusing specifically on the differentially regulated cytokines and chemokines and their receptors between these tissues revealed a signature of lymphoid tissue induction, including secondary and tertiary lymphoid induction signals. We also found a strong type II (γ) interferogenic signal, which included expression of Cxcl10, Ccl5, Tnfsf10 (TRAIL), and Casp1 ( Figure 3C and Supplemental Table 2 ) (34). We further evaluated for differential expression of genes associated with posttranslational modification of the constituent proteins of peripheral node addressin (PNAd), typically expressed by high endothelial venules and important for the recruitment of naive and certain memory lymphocytes (35, 36) . We found upregulation of several PNAd components, including Chst3, Cmah, and St8sia4 (Supplemental Figure 1G ), which was supported by positive PNAd staining (Supplemental Figure 1E ). Selected genes differentially expressed between MRL/lpr and MRL/+ CP, including Ltb, Cxcl3, Ifng, and Ccr7, were validated by reverse transcription quantitative PCR (RT-qPCR) ( Figure 4 ). Interestingly, when evaluating 8-week-old MRL/lpr CP for expression of certain genes revealed by RNASeq, we found significant elevation of several cytokines and chemokines, including Ltb and Cxcl10, before there was any significant lymphocytic infiltration ( Figure 4 ). Finally, Gene Ontology (GO) assessment identified MRL/lpr CP expression signatures associated with lymphocyte migration and chemotaxislymphocyte migration (GO:0072676, P = 1.9E10 -8 ), lymphocyte chemotaxis (GO:0048247, P = 1.02E10 -5 ), and regulation of lymphocyte migration (GO:2000401, P = 1.12E10 -8 ) -further supporting concerted cell recruitment and organization in this tissue.
The CP infiltrate is organized according to chemokine gradients and intercellular interactions. We examined the MRL/lpr CP for CXCL13, a chemokine integral to lymphoid organization, and found extensive CXCL13 deposition localized in regions rich with B cells and follicular dendritic cells ( Figure 5A ). We similarly evaluated the CP cellular infiltrates for evidence of antigen presentation, finding both IBA1/CD4 interactions ( Figure 5B ) as well as MHCII/CD3 colocalization ( Figure 5C ), consistent with antigen presentation to T cells. Interactions between antigen-presenting cells and T cells were prominently apparent by scanning electron microscopy (SEM) as well ( Figure 5D ). Additionally, GO term analysis of MRL/lpr CP transcripts revealed significant enrichment for gene expression related to antigen presentation, the immunological synapse, and lymphocyte activation and stimulation (e.g., Lck, Zap70, Icos, Tap2, Cd28, and Cd80), further identifying T cell activation within the lymphoid structures ( Figure 6 ).
CP-infiltrating lymphocytes are phenotypically characteristic of lymphoid follicles with GC activity. After determining that the nature and organization of the cells infiltrating the CNS of mice with lupus were consistent with lymphoid aggregates generated in response to specific lymphoid tissue-inducing mediators, we characterized individual cell phenotype markers that define both the lymphoid follicle and GC reaction. Again, GO analysis provided valuable insight, identifying multiple stages of B cell maturation and differentiation as evidenced by enhanced transcription of various genes related to B cell maturation and GC activity, such as Klhl6, Ada, Tnfrsf13c (BAFF receptor), Tnfsf13b (BAFF), and Cdh17 ( Figure  7A ). Within the CD4 + T cell population, we identified expression of the transcription factor BCL6, which drives Tfh cell responses and is essential in the formation of GC with active somatic hypermutation (Supplemental Figure 1F) . Additionally, local proliferation of CD4 + cells was evident by PCNA costaining (Supplemental Figure 1B) , suggesting in situ activation. Upon further characterization of the B cell population, we found B220 + /IgM + cells (transitional B cells pending activation; Figure 7B ), as Figure 1D ), all subsets typically found in lymphoid follicles. Additionally, there were localized clusters of SDC1 + (CD138 + ) plasma cells, with the majority positive for cytosolic IgG ( Figure 7D ).
Ultrastructural evaluation of the lupus CP revealed extensive inflammatory pathology and T cell dissemination to the CNS across the CP epithelium. Further evaluation of the CP was performed by electron microscopy because this modality allows for direct evaluation of intercellular interactions as well as subcellular features of the tissue, including cell localization. TEM revealed that lymphocytes were often found engulfed by CP epithelial cells and localized within their membrane borders ( Figure 8A ), with no apparent disruption of interepithelial tight junctions ( Figure 9B ), which together are strongly suggestive of transepithelial T cell migration, a finding that we recently described more extensively elsewhere (37) . SEM demonstrated a normal-appearing CP in MRL/+ mice ( Figure 8B ), whereas there was extensive leukocyte infiltration and stromal expansion in the MRL/lpr mice ( Figure 8C ). TEM further confirmed the presence of clusters of leukocytes and plasma cells within the CP stroma ( Figure 9A ). Evaluation of the villous processes of the CP by TEM revealed several striking inflammatory features. Most remarkable was the gross distortion of the epithelial basement membrane, including extensive thickening and deposition of a granular, osmophilic substance ( Figure 9C ). This finding is consistent with antibody or immune complex deposition, much as described in the CP of patients with SLE (16, 38). As mentioned above, intercellular junctional complexes were intact, suggesting that crossing of any cell or substance into the cerebrospinal fluid (CSF) space would occur in a transcellular fashion.
Leukocyte infiltration occurs through the CP of SLE patients with neuropsychiatric disease. We screened the Montefiore Medical Center (Bronx, New York) patient database for those individuals with a diagnosis of SLE who underwent brain assessment at autopsy. Archival tissue including the CP of the lateral and fourth ventricles was sampled and stained for the pan-leukocyte marker CD45. Patients (n = 12) had a median age of 45.5 ± 15.9 at the time of autopsy; 75% were female, 40% were African-American, and 60% were Hispanic. At the time of death, only 2 patients had evidence of significant cerebrovascular disease, whereas the majority had other neuropsychiatric conditions, including depression, chronic headache, seizure disorder, altered mental status, and psychosis. Two were found to have intrathecal fungal disease and were consequently excluded from histological analysis. We found that the CP served as a site for leukocyte migration into the CNS in several patients with lupus, including instances of larger groupings of lymphocytes ( Figure 10) . Interestingly, when evaluating leptomeningeal structures and associated perivascular Virchow-Robin spaces, we routinely found substantial numbers of lymphocytes, as well as cells penetrating into adjacent parenchyma (data not shown). Figure 3C , were evaluated by RT-qPCR at 8 and 16 weeks of age. Evaluation at 8 weeks of age revealed high expression of genes related to GC formation (Ltb) and IFN-γ activity (Cxcl10). Mean ± standard error of the mean values are shown; n = 5. Two-tailed Student's t test. ***P < 0.001; ****P < 0.0001.
Discussion
Although there have been previous reports identifying several of the cell types present within the CP of MRL/lpr mice (20, 31) , there has been very little characterization of the mechanisms through which they infiltrate and the functional consequences of their presence. We found that infiltrating cells in the CP of NPSLE mice generate TLSs, with in situ GC activity, likely in response to an elaborate transcriptional signature that includes typical signaling axes as well as potential involvement of novel pathways. We have additionally found that the CP epithelium serves as a trafficker of lymphocytes in a concerted transepithelial fashion from subepithelial stroma into the ventricles.
The pathogenesis of NPSLE is complex and multifactorial. Nevertheless, as in the case of other lupus-related pathologies, it is believed that autoantibodies may be important contributors (39, 40) . However, the relationship between serum autoantibodies and brain pathology in SLE is inconsistent (41) (42) (43) (44) . Although there has been speculation regarding potential routes of entry for neuropathic autoantibodies into the CNS of patients with SLE (45), there is little direct evidence of blood-brain barrier (BBB) or other blood-CNS barrier disruption (46) . This does not, however, preclude production of neuropathic autoantibodies in localized, ectopic lymphoid structures, as has been recently reported in lupus nephritis (22) . Furthermore, this could help account for the variable seropositivity of patients with NPSLE as well. Given the restrictiveness of the BBB, the role of the CP in mediating neuroimmunopathology has also recently grown in importance. The CP functions as an important neuroimmune interface under basal physiological conditions (12, 47) , as well as in inflammation (14, 48) . Additionally, the CP has been implicated in human NPSLE, as evidenced by MRI (18, 49) as well as anecdotal reports identifying IgG deposition within the CP basement membrane in biopsy samples (16) . Furthermore, our recent work evaluating BBB function and routes of immune penetration into the CNS has proved revealing in the model used herein; BBB function in particular as it relates to interendothelial tight junctions appears to be mostly conserved, and the CP is in fact a conduit for immunoglobulin transmission and lymphocyte migration (37) . The various potential modes of immune migration through the CNS in SLE have been recently reviewed, including discussion of the relative roles of the BBB and CP, as well as the potential involvement of dural lymphatics and the glymphatic pathways (46) .
Our discovery of lymphoid structures in the CP is supported by several other recent observations that collectively suggest that the cognitive and emotional deficits found in NPSLE may not rely solely on systemic autoimmunity. Specifically, the onset of NPSLE occurs well before there is a systemic autoimmune burden in MRL/lpr mice (7), and neuropsychiatric manifestations are frequently an early feature of pediatric SLE (9) . Moreover, using bone marrow transplantation to arrest autoimmunity in MRL/lpr mice, we found little change in behavioral outcomes despite near reversal of systemic disease (4). Additionally, tissue-specific TLSs have been found in various autoimmune states, allowing for the generation of immune responses to localized antigens (28) . This occurs separately from traditional modes of acute leukocytic infiltration resulting from remote antigen presentation and most frequently is found in cases of chronic inflammation, both in mouse models and in humans, as a consequence of stimulation by soluble molecules, including LT (50) and CXCL13 (23). Figure 6 . MRL/lpr CP gene expression profile is consistent with antigen presentation and its effects. Evaluation of 120 distinct genes linked to GO terms associated with T cell activation and antigen presentation (GO:0019886, GO:0002579, GO:0031295, GO:0001772, and GO:0043370), revealed increased expression of 66 genes relating to these processes. Selected critical genes are denoted by 3 red asterisks.
Notably, however, robust lymphocytic infiltration and cell-mediated inflammation is not a common finding within the CNS parenchyma of SLE patient tissue examined postmortem. We believe that this is likely a consequence of tissue analysis in patients who have been treated with long-term or at least recent potent cytotoxic medications. Indeed, skin and renal biopsies performed on SLE patients with active disease are routinely positive for mononuclear infiltrates, including previously described TLSs described in the kidney (51). Similarly, when MRL/lpr mice are treated with aggressive immunosuppression with cyclophosphamide (a cytotoxic agent), they experience attenuated behavioral abnormalities and modulation of cellular infiltrates (52) .
RNA-Seq proved to be a powerful tool in identifying the complex and multifaceted transcriptional activity that feeds into TLS generation. When evaluating the CP of diseased MRL/lpr mice, we found marked elevation of many chemotactic factors, including Cxcl-9, -10, -11, -13, and -19, as well as Ccl-3, -4, -5, -6, -7, -8, -12, -19 , and -22. Of these, Cxcl13 and Ccl19 are canonical factors in the lymphoid organization of B and T lymphocytes, respectively. Importantly, in the chronic inflammation associated with NPSLE, these chemokines are likely effectors in the recruitment and organization of leukocytes in the formation of a TLS. Other key molecules in the in situ generation of lymphoid structures mediate LT-α/-β signaling, a pathway highly expressed in the transcriptomic signature of the lupus CP. Interestingly, when evaluating the CP of young MRL/lpr mice well before any significant lymphocytic infiltration, we were surprised to find robust expression of Ltb, Ifng, Tnfa, Ccl5, and Cxcl10, indicating that the process of TLS generation is likely driven by CP epithelial-or even parenchyma-derived signaling. In future studies, it will be interesting to parse out these early, initiating events in this process.
It is important to point out some potential limitations of the bulk RNA-Seq approach, including that enrichment of specific genes may be a function of the number of infiltrating cells and that the expression of genes related to GC responses in CP-infiltrating immune cells may be further appreciated by a comparison to immune cells isolated from unaffected tissues. Nevertheless, we did include data from lymph nodes. Moreover, the bulk RNA-Seq results were supplemented and supported by the comprehensive immunofluorescence studies. Using single-cell sequencing techniques in future studies, along with analytical tools that allow for determination of T cell and B cell receptor clonality at the single-cell level, will facilitate a closer look at these and related questions. Similarly, direct evaluation of the pathogenicity of B cell clones or their antibody products through adoptive transfer studies would be valuable.
When evaluating the cellular phenotypes of the CP infiltrate, we found many features that strongly supported the presence of TLSs. The structural features of lymphoid organs were apparent, including reticular fibers and collagen bundles and distinct B and T cell domains. We found that B cells were clustered according to chemokine gradients and were regionally colocalized with CD21 + follicular dendritic cells, as is expected for antigen presentation to B cells. Similarly, T cells were regionally colocalized with IBA1 + cells and had membrane colocalization with MHCII on neighboring cells. We further found cells expressing markers characteristic of various stages of B cell development, including 
transitional, activated, and GC B cells, along with activated CD4
+ and Tfh cells. GC activity was supported by RNA-Seq as well, with several genes, including Klhl6 (B cell receptor signal transduction), Ada (GC B cell survival), Tnfrsf13c (BAFF receptor), and Tnfsf13b (BAFF), showing high transcript levels (53, 54) . Finally, evidence of lymphocyte migration through the CP appears to be a feature of NPSLE in patients as well. Interestingly, in addition to those found in the CP, we routinely found CD45 + cells in the pia-lined perivascular space of penetrating vessels (aka Virchow-Robin space). This potential space, which is anatomically contiguous with the ventricles, has been found to house the aforementioned glymphatic system. It is tempting to speculate that the CP stroma functions as a leukocyte conduit, fed by the fenestrated choroidal vasculature and the hyperpermissive epithelium, rather than through the highly impermeable parenchymal BBB vessels.
To identify the role of CXCL13, an essential chemokine for the recruitment of naive B cells to TLSs, we chose to use staining protocols to maximize the identification of the secreted, interstitial CXCL13 signal. Consequently, the pattern of staining we identified demonstrated CXCL13 on the surface of B220 + (B cells), which would express CXCR5 (the receptor for CXCL13). Moreover, CD21
+ cells consist of an extensive network of processes extending from a small number of cell bodies, which would not typically be evident in the thin-section microscopy we used, whether in primary or secondary lymphoid tissue or in the TLSs demonstrated here. Finally, because we are describing an atypical lymphoid structure occurring in a tissue not previously described to have this capacity, staining patterns may not be identical to those of primary or secondary lymphoid organs.
Further supporting the identification of the mixed lymphoid aggregates in the CP of MRL/lpr as TLSs are our recent studies of the T cell population (55) . We found that a subset of CP-infiltrating CD4 + T cells in MRL/lpr mice displayed a Tfh-like phenotype, as evidenced by their surface markers and IL-21 expression. Moreover, flow cytometric analysis confirmed the significant expression of IFN-γ and BCL6 in these cells, consistent with the RNA-Seq data described in the current paper. Importantly, while T cell infiltration is also present in other organs in the MRL/lpr strain (e.g., lung), those infiltrates include a significant number of double-negative T cells (56) . Double-negative T cells, however, were not increased in the CP (Figure 1 and  ref. 55 ), further supporting a specific immunological process involving structure and organization in this unique tissue, rather than passive lymphocytic accumulation.
Future studies to conclusively confirm the pathogenicity of the CP-localized TLSs that develop in parallel with worsening behavioral disease, including their disruption by various pharmacological or genetic means, will be an important next step. Nevertheless, we have previously demonstrated that knock out of Fn14 (TNFSF12 receptor) decreases the extent of CP lymphocyte infiltration, with concomitant improvement in behavioral outcomes (21) . Interestingly, TLS formation has been recently linked to the pathogenesis of lupus nephritis, a major contributor to SLE-related mortality. Moreover, several studies have evaluated mice with lupus and human lupus tissue, finding that BAFF (51) and CXCL13 (57) are contributors to TLS formation in the kidney. Furthermore, clonotypic plasma cell responses with in situ somatic hypermutation have been demonstrated in human lupus kidney biopsies (22) . It is interesting to speculate whether any of the beneficial effects of BAFF inhibition in human lupus are mediated through perturbation of TLS formation.
The CNS is quite unique immunologically and is likely not as susceptible to the formation of lymphoid aggregates as other tissue types, such as the synovium (23), kidney (22) , and large vessels (50) . The blood-brain and blood-CSF barriers tightly regulate movement of both cellular and soluble immune effectors into the CNS. Even in the case of multiple sclerosis, ectopic lymphoid follicles were not found within CNS parenchyma, but rather in the meninges (58) , which have been recently identified as a region rich in lymphatics with potent immunosurveillant functions (11) . Lymphatic vasculature, however, is not thought to be present within brain tissue, which is reliant on the glymphatic system for clearance of interstitial fluid and soluble material (10) . We should point out that with rare exceptions tissue sampling is not a routine component of the diagnosis and management of chronic CNS disease processes, including neuropsychiatric lupus, thus limiting the ability to monitor progressive immune activity in the clinical realm as well as quickly perform parallel studies to those performed here in human lupus. Although we did find evidence of lymphocytic clustering in the region of the CP in several patients with NPSLE, which suggests an important translational link to our murine lupus studies, definitive conclusions await the study of additional patients. An alternative approach, which we and others are actively pursuing, is the use of advanced radiographic tools to noninvasively track immune activity at the high resolution required for this purpose.
Localized deep within the CNS and the major producer of its fluid phase, the CP is uniquely positioned to fulfill many immunoregulatory roles. Importantly, as opposed to the endothelial barrier in the majority of the CNS, the CP vasculature is fenestrated, with the epithelium providing barrier and selective transport functions. Additionally, beyond its importance in production of CSF, the CP epithelium can direct cellular traffic by localized chemokine secretion. Finally, the vasculature of the CP is indeed a sprawling plexus, allowing for rapid transmission and dissemination of cells and soluble molecules throughout the subepithelial stroma. Collectively, these features not only allow for effective immune interfacing but also are likely an essential component in the development of the lymphoid structures we identified in NPSLE. TLSs may present with high endothelial venules and a new lymphatic supply (50, 59) , in a process akin to neovascularization that occurs in tumor growth. Because a lymphatic system associated with this TLS has yet to be conclusively identified, our results suggest that the CP and its fenestrated capillary plexus and basal immunosurveillant functions may be uniquely able to facilitate leukocyte migration and homing. Furthermore, while we found elevated Glycam1 expression (a component of the PNAd complex), immunofluorescence demonstrated a cellular (but not vascular) pattern of PNAd expression interspersed throughout the infiltrate (Supplemental Figure 1E) . This finding, when coupled with high expression of glycosyltransferase transcripts, including Cmah, Chst3, St8sia4, and St4gal6, strongly suggests that PNAd substituent proteins are undergoing local posttranslational modification (60) and that leukocyte trafficking into the TLS may be directed by elements other than the vasculature, which is what typically occurs in secondary lymphoid organs.
Our findings provide for an important contribution to the evolving understanding of the CP as a neuroimmune interface, namely that CP epithelium is capable of supporting lymphoid follicle generation in situ. These structures, which contain the hallmark transcriptional signatures and cells of the GC, were generated in response to a complex expression pattern of critical signaling molecules and may represent yet another important mechanism by which the CP interacts with the immune system, particularly in cases of chronic neuroimmunological disease. Future studies will be directed at determining the pathogenicity of autoreactive antibodies produced in situ, as well as chemotactic factors involved in leukocyte recruitment in patients with NPSLE. Together, these future studies may identify potential therapeutics for managing the neuropsychiatric complications of SLE.
Methods
Animals. Female MRL/MpJ-Fas lpr/lpr (MRL/lpr) and MRL/MpJ-Fas +/+ (MRL/+) mice were purchased from the Jackson Laboratory at 5-8 weeks of age and housed at 21°C-23°C on a 12-hour light/12-hour dark cycle. All animal protocols were approved by the Albert Einstein College of Medicine Institutional Animal Care and Use Committee.
Tissue preparation. Age-matched MRL/lpr and control MRL/+ mice were sacrificed between 5 and 16 weeks of age, representing the time frame from well before CP cellular infiltration through widespread infiltration in the majority of MRL/lpr mice. Mice were perfused with PBS (Corning) before brain isolation and subsequent tissue processing. The CP from all ventricles was isolated and flash-frozen in liquid nitrogen for subsequent RNA isolation from several cohorts of 4-6 mice. Additional mice at 5 (n = 5), 8-9 (n = 9), and 16-17 (n = 12) weeks of age were perfused with PBS followed by 2.5% paraformaldehyde (PFA; MilliporeSigma) and postfixed in 2.5% PFA at 4°C followed by processing for paraffin sectioning.
Archival autopsy tissue from patients with NPSLE was identified from within the Montefiore Medical Center patient database. Exclusion criteria included active CNS infection at time of death, history of intrathecal neoplasm, and prolonged immunosuppression. In particular, younger patients with NPSLE were identified to minimize confounding by long-standing disease and age-related degenerative or neurovascular complications.
RNA isolation and downstream analysis. RNA isolation from CP tissue was performed with the Zymo Research Micro Prep Kit. For RT-qPCR, RNA concentration and quality were evaluated by Nanodrop (Thermo Fisher Scientific). cDNA of total mRNA was generated using the Superscript III First Strand Synthesis kit with poly(A) tail primers (Life Technologies). RT-qPCR was performed in triplicate as described elsewhere (21) . For RNA-Seq, RNA yield and quality were evaluated using a Bioanalyzer RNA 6000 Nano Chip (Agilent). RNA samples from the CP of 12-to 16-week-old MRL/lpr (n = 12) and MRL/+ (n = 6) mice were multiplexed and sequenced over 2 lanes for single-end 100-bp reads on a HiSeq2500 instrument (Illumina) using the TruSeq Library Prep Kit v2 (Illumina). The RNA-Seq data described below have been deposited in Gene Expression Omnibus (GEO) (61) and are accessible through accession GSE99030 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=cvqpooeorvojran&acc=GSE99030).
Publicly available RNA-Seq data for unmanipulated 12-week-old C57BL/6J lymphoid tissue were obtained from the National Center for Biotechnology Information's GEO using data set numbers GSM1533040-1, GSM1533051-3, and GSM1533060-2 (47) . Demultiplexed FASTQ files were aligned to the mouse reference genome GRCm38 using STAR aligner (version 2.5.3a) (62) . The STAR reference index was created using a transcript annotation in a general transfer format (GTF) file from Ensembl release 88. Uniquely mapped reads to the reference genome were counted using featureCounts (version 1.26.0) (63) and the Ensembl 88 GTF by collapsing on the gene level. For all differentially expressed genes, data are represented as natural log-transformed transcripts per million with row means subtracted. Gene ontology was evaluated using the GO Consortium annotation and ontology tool kit (64) .
Immunostaining. PFA-fixed tissue was paraffin embedded and 5-μm sections were used for the majority of stains, with the exception of CD3/MHCII and CD4/IBA1 staining, which were performed on 7-to 10-μm frozen sections (without the need for antigen retrieval). Fluorescent staining was performed as described elsewhere (4); antibodies, concentrations, and antigen retrieval conditions are provided in Supplemental Table 1 . Tissue was treated with minimal detergents to prevent washout of interstitial and cell surface chemokine deposits. For all stains, control MRL/+ mice were included and primary antibodies were routinely withheld to control for nonspecific secondary staining. Chromogenic staining of human tissue was performed similarly, with the additional use of DAB and hematoxylin counterstaining (VWR). All secondary antibodies were purchased from Jackson Immunoresearch. Slides were visualized using a Thermo Fisher Scientific Evos FL Auto2. Secondary antibody controls were used for all staining, and image acquisition was adjusted to show signals only above the background defined by secondary antibody control staining.
Electron microscopy. For TEM, brains were dissected and fixed as described previously (65), then examined under a JEOL 1400Plus electron microscope at 80 kV. Samples for SEM were prepared as described previously (66) and examined under a Zeiss Supra Field Emission Scanning Electron Microscope, using an accelerating voltage of 2 kV.
Statistics. Statistical evaluation and graphing of RT-qPCR were performed using GraphPad Prism. CP RT-qPCR data were calculated using the ΔΔCt method, normalized to expression of Ppia, and logarithmically scaled. Significant differences between groups were calculated by analysis with a 2-tailed Student's t test. Statistical significance was defined as a P value of less than 0.05. For RNA-Seq, differential expression analysis was performed using DESeq2 (version 1.16.1) (67) and R (version 3.3.3), as described previously (68, 69) . 
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